{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T20:57:27Z","timestamp":1763499447634,"version":"3.41.2"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,7,26]],"date-time":"2018-07-26T00:00:00Z","timestamp":1532563200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2018.00765","type":"journal-article","created":{"date-parts":[[2018,7,26]],"date-time":"2018-07-26T14:03:41Z","timestamp":1532613821000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Optimal Regimens and Cutoff Evaluation of Tildipirosin Against Pasteurella multocida"],"prefix":"10.3389","volume":"9","author":[{"given":"Zhixin","family":"Lei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haseeb","family":"Khaliq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jincheng","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gopi Krishna","family":"Moku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeed","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenqiu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiyue","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qigai","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2018,7,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2015.00588","article-title":"Integration of PK\/PD for dose optimization of Cefquinome against Staphylococcus aureus causing septicemia in cattle.","volume":"6","author":"Ahmad","year":"2015","journal-title":"Front. Microbiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0924-8579(00)00142-4","article-title":"Antibiotic treatment for animals: effect on bacterial population and dosage regimen optimisation.","volume":"14","author":"Aliabadi","year":"2000","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.2460\/ajvr.2001.62.1979","article-title":"Pharmacokinetics and pharmacodynamics of danofloxacin in serum and tissue fluids of goats following intravenous and intramuscular administration.","volume":"62","author":"Aliabadi","year":"2001","journal-title":"Am. J. Vet. Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1046\/j.1365-2885.2002.00399.x","article-title":"Pharmacokinetics and pharmacodynamic integration of marbofloxacin in calf serum, exudates and transudate.","volume":"25","author":"Aliabadi","year":"2002","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"B5","doi-asserted-by":"publisher","first-page":"6033","DOI":"10.1128\/AAC.01250-12","article-title":"Inhibition of protein synthesis on the ribosome by tildipirosin compared with other veterinary macrolides.","volume":"56","author":"Andersen","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"B6","doi-asserted-by":"publisher","first-page":"19S","DOI":"10.1378\/chest.115.suppl_1.19S","article-title":"Pharmacodynamic principles of antimicrobial therapy in the prevention of resistance.","volume":"115","author":"Burgess","year":"1999","journal-title":"Chest"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1016\/S0149-2918(00)86736-3","article-title":"Pharmacokinetics and pharmacodynamics of aztreonam administered by continuous intravenous infusion.","volume":"21","author":"Burgess","year":"1999","journal-title":"Clin. Ther."},{"key":"B8","doi-asserted-by":"publisher","first-page":"3857","DOI":"10.1128\/AAC.00048-12","article-title":"Population pharmacokinetics and pharmacodynamics of ofloxacin in South African patients with multidrug-resistant tuberculosis.","volume":"56","author":"Chigutsa","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"journal-title":"The Methods for Dilution Antimicrobial Susceptibility Determination.","year":"2012","key":"B9"},{"key":"B10","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/jvp.12385","article-title":"Pharmacokinetic\/pharmacodynamic integration and modelling of oxytetracycline for the porcine pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida.","volume":"40","author":"Dorey","year":"2017","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"B11","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/jvp.12489","article-title":"Pharmacokinetics of cefquinome in healthy and Pasteurella multocida-infected rabbits.","volume":"41","author":"Elazab","year":"2018","journal-title":"J. Vet. Pharmacol. Ther."},{"journal-title":"Committee for Medicinal Products for Veterinary Use.","year":"2010","key":"B12"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1100\/2012\/685028","article-title":"Virulence genes and antimicrobial resistance profiles of Pasteurella multocida strains isolated from rabbits in Brazil.","volume":"2012","author":"Ferreira","year":"2012","journal-title":"Sci. World J."},{"key":"B14","doi-asserted-by":"publisher","first-page":"3779","DOI":"10.1128\/AAC.00711-05","article-title":"Integration of pharmacokinetic and pharmacodynamic indices of marbofloxacin in turkeys.","volume":"50","author":"Haritova","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"B15","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1128\/JCM.30.11.2984-2987.1992","article-title":"Characterization and distribution of Pasteurella species recovered from infected humans.","volume":"30","author":"Holst","year":"1992","journal-title":"J. Clin. Microbiol."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1186\/s12917-015-0604-5","article-title":"In vitro dynamic pharmacokinetic\/pharmacodynamic (PK\/PD) study and COPD of marbofloxacin against Haemophilus parasuis.","volume":"11","author":"Jian","year":"2015","journal-title":"BMC Vet. Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/jvp.12207","article-title":"Pharmacokinetic\/pharmacodynamic integration and modelling of amoxicillin for the calf pathogens Mannheimia haemolytica and Pasteurella multocida.","volume":"41","author":"Lees","year":"2015","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-03970-9","article-title":"Pharmacokinetic and pharmacodynamic modeling of cyadox against Clostridium perfringens in swine.","volume":"7","author":"Lei","year":"","journal-title":"Sci. Rep."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00542","article-title":"Pharmacokinetic and pharmacodynamic evaluation of marbofloxacin and PK\/PD modeling against Escherichia coli in pigs.","volume":"8","author":"Lei","year":"","journal-title":"Front. Pharmacol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.18632\/oncotarget.23018","article-title":"The pharmacokinetic-pharmacodynamic modeling and cut-off values of tildipirosin against Haemophilus parasuis.","volume":"9","author":"Lei","year":"","journal-title":"Oncotarget"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2017.00061","article-title":"Evaluation of bioequivalence of two long-acting 20% oxytetracycline formulations in pigs.","volume":"4","author":"Lei","year":"","journal-title":"Front. Vet. Sci."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00306","article-title":"Evaluation of marbofloxacin in beagle dogs after oral dosing: preclinical safety evaluation and comparative pharmacokinetics of two different tablets.","volume":"9","author":"Lei","year":"","journal-title":"Front. Pharmacol."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00002","article-title":"PK-PD integration modeling and cutoff value of florfenicol against Streptococcus suis in pigs.","volume":"9","author":"Lei","year":"","journal-title":"Front. Pharmacol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/j.1365-2885.2011.01349.x","article-title":"Pharmacokinetics of tildipirosin in bovine plasma, lung tissue, and bronchial fluid (from live, nonanesthetized cattle).","volume":"35","author":"Menge","year":"2012","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1093\/jac\/dks076","article-title":"Increased MICs of gamithromycin and tildipirosin in the presence of the genes erm(42) and msr(E)-mph(E) for bovine Pasteurella multocida and Mannheimia haemolytica.","volume":"67","author":"Michael","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"B26","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0924-8579(02)00031-6","article-title":"Standardization of pharmacokinetic\/pharmacodynamic (PK\/PD) terminology for anti-infective drugs: an update.","volume":"19","author":"Mouton","year":"2002","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B27","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/sim.2542","article-title":"Diagnostics for confounding in PK\/PD models for oxcarbazepine.","volume":"26","author":"Nedelman","year":"2007","journal-title":"Stat. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"4973","DOI":"10.1128\/AAC.06402-11","article-title":"Correlation between fecal concentrations of ciprofloxacin and fecal counts of resistant Enterobacteriaceae in piglets treated with ciprofloxacin: toward new means to control the spread of resistance?","volume":"56","author":"Nguyen","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1124\/pr.111.005769","article-title":"Pharmacokinetic-pharmacodynamic modeling of antibacterial drugs.","volume":"65","author":"Nielsen","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"B30","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1093\/jac\/dku385","article-title":"Macrolide resistance conferred by rRNA mutations in field isolates of Mannheimia haemolytica and Pasteurella multocida.","volume":"70","author":"Olsen","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"B31","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.drup.2010.09.002","article-title":"Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methods.","volume":"13","author":"Pfaller","year":"2010","journal-title":"Drug Resist. Updat."},{"key":"B32","doi-asserted-by":"publisher","first-page":"3800","DOI":"10.1128\/JCM.05047-11","article-title":"Triazole and echinocandin MIC distributions with epidemiological cutoff values for differentiation of wild-type strains from non-wild-type strains of six uncommon species of Candida.","volume":"49","author":"Pfaller","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1021\/cb300105p","article-title":"Visualizing the 16-membered ring macrolides tildipirosin and tilmicosin bound to their ribosomal site.","volume":"7","author":"Poehlsgaard","year":"2012","journal-title":"ACS Chem. Biol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.1365-2885.2005.00677.x","article-title":"PK-PD modeling of buprenorphine in cats: intravenous and oral transmucosal administration.","volume":"28","author":"Robertson","year":"2005","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"B35","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1365-2885.2012.01397.x","article-title":"Pharmacokinetics of tildipirosin in porcine plasma, lung tissue, and bronchial fluid and effects of test conditions on in vitro activity against reference strains and field isolates of Actinobacillus pleuropneumoniae.","volume":"36","author":"Rose","year":"2013","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2015.00080","article-title":"Pharmacokinetic\u2013pharmacodynamic modeling of enrofloxacin against Escherichia coli in broilers.","volume":"2","author":"Sang","year":"2016","journal-title":"Front. Vet. Sci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.rvsc.2009.05.013","article-title":"PK-PD integration and modeling of marbofloxacin in sheep.","volume":"88","author":"Sidhu","year":"2010","journal-title":"Res. Vet. Sci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1111\/j.1365-2885.2010.01247.x","article-title":"Pharmacokinetic and pharmacodynamic modelling of marbofloxacin administered alone and in combination with tolfenamic acid in calves.","volume":"34","author":"Sidhu","year":"2011","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"B39","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1128\/JCM.02029-08","article-title":"Isolation, antimicrobial resistance, and virulence genes of Pasteurella multocida strains from swine in China.","volume":"47","author":"Tang","year":"2009","journal-title":"J. Clin. Microbiol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/jvp.12258","article-title":"Pharmacokinetics of tildipirosin in pig tonsils.","volume":"39","author":"Torres","year":"2016","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.02344","article-title":"En route towards European clinical breakpoints for veterinary antimicrobial susceptibility testing: a position paper explaining the VetCAST approach.","volume":"8","author":"Toutain","year":"2017","journal-title":"Front. Microbiol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0034-5288(02)00039-5","article-title":"The pharmacokinetic\u2013pharmacodynamic approach to a rational dosage regimen for antibiotics.","volume":"73","author":"Toutain","year":"2002","journal-title":"Res. Vet. Sci."},{"key":"B43","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/jvp.12333","article-title":"Standard PK\/PD concepts can be applied to determine a dosage regimen for a macrolide: the case of tulathromycin in the calf.","volume":"40","author":"Toutain","year":"2016","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"B44","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1128\/CMR.00047-06","article-title":"Setting and revising antibacterial susceptibility breakpoints.","volume":"20","author":"Turnidge","year":"2007","journal-title":"Clin. Microbiol. Rev."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.00036","article-title":"Pharmacokinetic and pharmacodynamic integration and modeling of enrofloxacin in swine for Escherichia coli.","volume":"7","author":"Wang","year":"2016","journal-title":"Front. Microbiol."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1186\/s12917-015-0343-7","article-title":"In vitro dynamic pharmacokinetic\/pharmacodynamic(PK\/PD) modeling and PK\/PD cutoff of cefquinome against Haemophilus parasuis.","volume":"11","author":"Xiao","year":"2015","journal-title":"BMC Vet. Res."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.00385","article-title":"The epidemiologic and pharmacodynamic cutoff values of tilmicosin against Haemophilus parasuis.","volume":"7","author":"Zhang","year":"2016","journal-title":"Front. Microbiol."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-07972-5","article-title":"Comparative transcriptional profiling of tildipirosin-resistant and sensitive Haemophilus parasuis.","volume":"7","author":"Zhixin","year":"2017","journal-title":"Sci. Rep."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2018.00765\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T19:53:44Z","timestamp":1604692424000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2018.00765\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,26]]},"references-count":48,"alternative-id":["10.3389\/fphar.2018.00765"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2018.00765","relation":{},"ISSN":["1663-9812"],"issn-type":[{"type":"electronic","value":"1663-9812"}],"subject":[],"published":{"date-parts":[[2018,7,26]]},"article-number":"765"}}